Rituximab in dermatology: Revisited
Rituximab (RTX) is a specific mouse and human chimeric monoclonal antibody that has found to have numerous applications in dermatology. Though initially approved by the US FDA for treating rheumatoid arthritis and non-Hodgkin's lymphoma; currently its approval has extended to involve the pemphi...
Main Author: | Aditya Kumar Bubna |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Drugs in Dermatology |
Subjects: | |
Online Access: | http://www.ijdd.in/article.asp?issn=2455-3972;year=2020;volume=6;issue=1;spage=5;epage=12;aulast=Bubna |
Similar Items
-
Tracheotomy avoided in laryngeal mucous membrane pemphigoid treated with rituximab
by: Daniela A. Brake, et al.
Published: (2020-06-01) -
Rituximab for the treatment of pemphigus and pemphigoid: A case series of ten patients
by: Safaa S Alwaash, et al.
Published: (2019-01-01) -
Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
by: Aniek Lamberts, et al.
Published: (2018-02-01) -
Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid
by: W. Bernauer, et al.
Published: (2018-08-01) -
Vesiculobullous autoimmune diseases with oral mucosa manifestations: retrospective and follow-up study
by: Rani Iani Costa GONÇALO, et al.
Published: (2018-03-01)